Resistance to Dolutegravir in Treatment-experienced Patients in South Africa: A Retrospective Cohort Study.

J Acquir Immune Defic Syndr · 2025 · PMC7617472 · PMID 40029237

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

13 An increasing trend of dolutegravir resistance among adults receiving dolutegravir-based ART with HIV-1 RNA ≥1000 copies/mL and confirmed dolutegravir exposure using liquid tandem chromatography mass spectrometry was observed between two South African national surveys (2.7% and 11.9% in 2021 and 2022, respectively). 1

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.